2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theScleritis Market?
The increasing prevalence of autoimmune diseases is expected to drive the growth of the scleritis market. Autoimmune diseases are conditions where the body’s immune system mistakenly attacks healthy cells and tissues, thinking they are foreign invaders. The rise in autoimmune diseases is linked to genetic predispositions, environmental factors, lifestyle changes, and increased awareness, leading to better diagnosis. Autoimmune diseases cause scleritis by triggering an inflammatory immune response that attacks the scleral tissue, causing pain and redness. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, yielding a raw prevalence rate of 8.61%. Therefore, the rise in autoimmune diseases is driving the growth of the scleritis market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21283&type=smp
#What Are the Key Projections for the CAGR of the Scleritis Market From 2025 to 2034?
The scleritis market has expanded rapidly, increasing from $3.60 billion in 2024 to $3.94 billion in 2025 at a CAGR of 9.3%. This growth has been fueled by an increasing prevalence of autoimmune disorders, a rise in awareness of ocular health, an aging population, improved access to ophthalmic care, and advancements in global healthcare infrastructure.
The scleritis market is poised for strong growth, reaching $5.54 billion by 2029 at a CAGR of 8.9%. Growth drivers include an increasing incidence of eye-related health conditions, rising awareness of ocular health, higher healthcare expenditures, expanding ophthalmology research, and the demand for personalized treatments. Key industry trends include the development of targeted biologic therapies, advancements in immunosuppressive drug formulations, improvements in imaging technologies, adoption of minimally invasive diagnostic tools, increased focus on personalized medicine, advancements in drug delivery systems, and the application of AI in diagnostics and treatment planning.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21283
What Are the Current Market Growth and Trends in theScleritis Market That Industry Players Should Watch?
In the scleritis market, leading companies are focused on developing advanced products like eye drops to address inflammation and provide non-invasive treatment options. For example, in May 2023, Entod Pharmaceuticals launched CYCLOTEARS eye drops, which incorporate proprietary SEDDS technology to enhance drug delivery and efficacy. This novel therapy is designed to treat inflammatory eye diseases such as ocular myositis and scleritis, offering a significant advancement in eye inflammation treatment.
What Are the Major Market Players Making an Impact on theScleritis Market Growth?
Major companies operating in the scleritis market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceuticals USA Inc., Baxter International Inc., Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd., Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West-Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Zydus Pharmaceuticals Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report
How Are the Key Segments of the Scleritis Market Driving Opportunities and Innovations?
The scleritis market covered in this report is segmented –
1) By Type: Anterior Scleritis, Posterior Scleritis, Other Types
2) By Treatment: Medication, Surgery, Other Treatment
3) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channel
4) By End-Users: Hospitals, Specialty Clinics, Home Healthcare, Other End-Users
Subsegments:
1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis, Necrotizing Anterior Scleritis
2) By Posterior Scleritis: Diffuse Posterior Scleritis, Nodular Posterior Scleritis, Scleritis With Choroidal Involvement
3) By Other Types: Chronic Scleritis, Recurrent Scleritis, Infectious Scleritis
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=21283&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theScleritis Market?# Market Expansion?
North America was the largest region in the scleritis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Scleritis Market 2025, By The Business Research Company:
Hepatitis B Virus (HBV) Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report
Rotavirus Prophylaxis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report
Herpes Simplex Virus Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: